| |
|
|
|
Celldex Therapeutics  
|
|
22.07 -0.68 (-0.03%) |
11-30 12:08 |
|
Open: |
22.92 |
Pre close: |
22.75 |
Target:
|
27.33
|
|
High: |
22.96 |
Low: |
21.7386 |
Resistance:
|
23.40
27.33
|
|
Volume: |
218,643 |
Market Cap: |
873M |
Support:
|
17.94
14.56
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
22.12
 |
MACD |
MACD(12,26):
|
1.57 |
|
MA(20): |
19.62 |
Signal(12,26,9): |
1.34 |
|
MA(100): |
14.24 |
Stochastic Oscillator |
%K(14,3):
|
87.02  |
|
MA(250): |
7.85 |
%D(3): |
88.13 |
|
Average Volume(K) |
3-Month: |
68175
|
52-Week |
High:
|
23.40 |
|
10-Days: |
54747 |
Low: |
1.50 |
|
RSI |
RSI(14):
|
74.81 |
Change(%): |
793.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.030 |
Return on Equity (ttm) |
-29.2 |
Shares Out. (M) |
39.57 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-16.8 |
Shares Float (M) |
32.15 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.16 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
22.3 |
% Held by Institutions |
73.61 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
-0.988 |
Shares Short (K) |
2980 |
|
Book Value (p.s.) |
5.810 |
EBITDA (p.s.) |
-1.204 |
P/E |
-11.14 |
|
Sales Per Share |
0.114 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.89 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-46.19 |
P/S |
197.89 |
|
Operating Margin |
-1150.00 |
Levered Free Cash Flow
(M) |
-26.08 |
P/CF |
-19.37 |
|
|
|
|
|
|
